Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 29, 2003
Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors
S Goel, A Bulgaru, H Hochster, et al.
Current Opinion in Oncology
|
February 13, 1999
PSC833: initial clinical results in refractory ovarian cancer patients
A Fields, H Hochster, C Runowicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2002
Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer
X Pivot, S Wadler, C Kelly, et al.
Journal of Pain and Symptom Management
|
March 4, 2000
Management of cancer treatment-related diarrhea. Issues and therapeutic strategies
S Kornblau, A B Benson, R Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study
P J O'Dwyer, J Manola, F H Valone, et al.
Cancer
|
April 15, 1997
All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group
S Wadler, E L Schwartz, H Haynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2004
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV
K Shirao, P M Hoff, A Ohtsu, et al.
Biotechnology for Biofuels and Bioproducts
|
June 24, 2022
Utilization of lignocellulosic biofuel conversion residue by diverse microorganisms
Caryn S Wadler, John F Wolters, Nathaniel W Fortney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
S M Swain, F S Whaley, M C Gerber, et al.
British Journal of Cancer
|
September 5, 2001
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study
H J Andreyev, A R Norman, D Cunningham, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 29, 2003
Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors
S Goel, A Bulgaru, H Hochster, et al.
Current Opinion in Oncology
|
February 13, 1999
PSC833: initial clinical results in refractory ovarian cancer patients
A Fields, H Hochster, C Runowicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2002
Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer
X Pivot, S Wadler, C Kelly, et al.
Journal of Pain and Symptom Management
|
March 4, 2000
Management of cancer treatment-related diarrhea. Issues and therapeutic strategies
S Kornblau, A B Benson, R Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study
P J O'Dwyer, J Manola, F H Valone, et al.
Cancer
|
April 15, 1997
All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group
S Wadler, E L Schwartz, H Haynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2004
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV
K Shirao, P M Hoff, A Ohtsu, et al.
Biotechnology for Biofuels and Bioproducts
|
June 24, 2022
Utilization of lignocellulosic biofuel conversion residue by diverse microorganisms
Caryn S Wadler, John F Wolters, Nathaniel W Fortney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
S M Swain, F S Whaley, M C Gerber, et al.
British Journal of Cancer
|
September 5, 2001
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study
H J Andreyev, A R Norman, D Cunningham, et al.
Page
of 14